Cargando…
Management of retinitis pigmentosa by Wharton’s jelly-derived mesenchymal stem cells: prospective analysis of 1-year results
PURPOSE: The aim of the study was to investigate annual structural and functional results, and their correlation with inheritance pattern of retinitis pigmentosa (RP) patients who were treated with Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs). MATERIAL AND METHODS: This prospective, sequ...
Autores principales: | Özmert, Emin, Arslan, Umut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425139/ https://www.ncbi.nlm.nih.gov/pubmed/32787913 http://dx.doi.org/10.1186/s13287-020-01870-w |
Ejemplares similares
-
Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical results
por: ÖZMERT, Emin, et al.
Publicado: (2020) -
Management of Retinitis Pigmentosa Via Wharton’s Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results
por: Ozmert, Emin, et al.
Publicado: (2023) -
Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulation
por: Özmert, Emin, et al.
Publicado: (2021) -
Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013) -
Safety and Efficacy of Human Wharton's Jelly-Derived Mesenchymal Stem Cells Therapy for Retinal Degeneration
por: Leow, S. N., et al.
Publicado: (2015)